We report the first identification of a circulating peptide from the amino-
terminal end of proCNP. A specific radioimmunoassay was established based o
n antisera to the synthetic peptide proCNP(1-15). Extracts of plasma, drawn
from patients with congestive heart failure or from sheep with experimenta
l heart failure, were subjected to size exclusion and reverse-phase high-pr
essure liquid chromatography (HPLC) coupled to radioimmunoassay (RIA). Thes
e studies revealed the presence of an immunoreactive peptide with a molecul
ar weight (M-r approximately 5 kDa) similar to that expected for NT-proCNP(
1-50), a potential fragment released during processing of pro(CNP). The sam
e material was isolated from extracts of homogenized ovine pituitary, a tis
sue known to be a relatively enriched source of CNP. Plasma NT-proCNP level
s in 22 patients with congestive heart failure (9.7 +/-0.5 pmol/L, mean +/-
SEM, range 5.4-13.7 pmol/L) were raised (P=0.003) compared to those in 16
healthy volunteers (7.4 +/-0.3 pmol/L, range 5.7-10.7 pmol/L) and were high
er than levels reported for CNP in similar subjects. This first identificat
ion of circulating NT-proCNP opens the possibility of studying the factors
regulating CNP production and metabolism in vivo. (C) 2001 Academic Press.